blood cancer Archive — Page 3 of 5
-
April 7, 2022
Computer eyeballs graft-vs-host disease
A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy. -
March 28, 2022
Study finds 10-second videos predict blood cancer relapse
Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer. -
March 7, 2022
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease -
February 3, 2022
Children’s Hospital patients get creative for Vanderbilt Men’s Basketball team as part of Coaches vs. Cancer
-
December 9, 2021
Cell signaling targets in leukemia
Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments. -
April 20, 2021
The inside story behind the Hillsboro Village “Hope” mural: a brother’s love and a message for Children’s Hospital
Lance Gregory wanted the message to be visible from the windows of Children's Hospital — in memory of his brother Cory -
April 20, 2021
New therapeutic strategy for leukemia syndrome
Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.